Search

everythinglearnresearchcommunity

for

Search:↓

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

Stopping azathioprine led to full hair regrowth and recovery in 2.5 months.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.

Baricitinib for alopecia areata may rarely cause eye issues like keratitis.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

New treatments for lupus show promise, but more research is needed, especially for children.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A man with X-ALD improved after treatment, highlighting the need to consider X-ALD in similar patients and test their relatives.

Baricitinib was effective in treating hair loss in adults with alopecia areata according to patient feedback.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Betulinic acid can help treat hepatitis C by stopping virus replication.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

CT-707 is effective and safe for treating certain Chinese lung cancer patients.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Janus kinase inhibitors are effective for severe alopecia areata, promoting hair regrowth.

TNFα inhibitors are effective and well-tolerated for treating severe scalp cellulitis.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Intralesional corticosteroids effectively treat scalp Discoid Lupus and restore hair.

Combining baricitinib with UV-B therapy effectively treats non-segmental vitiligo and is well-tolerated.